Cargando…
Sertraline plus deanxit to treat patients with depression and anxiety in chronic somatic diseases: a randomized controlled trial
BACKGROUND: Patients in chronic somatic diseases are often accompanied with depression and anxiety, remission of which may be observed in the third or fourth week after applying common antidepressant medications. We investigate the efficacy and safety of sertraline plus deanxit on patients with depr...
Autores principales: | Wang, Limin, Zhong, Zhuoyuan, Hu, Jingyang, Rong, Xiaoming, Liu, Jun, Xiao, Songhua, Liu, Zhonglin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4403889/ https://www.ncbi.nlm.nih.gov/pubmed/25879863 http://dx.doi.org/10.1186/s12888-015-0449-2 |
Ejemplares similares
-
Melitracen and flupentixol (deanxit) use disorder in Lebanon
por: El Zahran, Tharwat, et al.
Publicado: (2023) -
Overexpression of NTRK1 Promotes Differentiation of Neural Stem Cells into Cholinergic Neurons
por: Wang, Limin, et al.
Publicado: (2015) -
Deanxit relieves symptoms in a patient with jackhammer esophagus: A case report
por: Li, Jin-Ying, et al.
Publicado: (2017) -
Deanxit and tandospirone relieved unexplained limb edema in a depressed pituitary adenoma survivor: A case report
por: Dong, Xingyu, et al.
Publicado: (2022) -
A meta-analysis of effects of selective serotonin reuptake inhibitors on blood pressure in depression treatment: outcomes from placebo and serotonin and noradrenaline reuptake inhibitor controlled trials
por: Zhong, Zhuoyuan, et al.
Publicado: (2017)